Ginsenosides in cancer: A focus on the regulation of cell metabolism

Biomed Pharmacother. 2022 Dec:156:113756. doi: 10.1016/j.biopha.2022.113756. Epub 2022 Oct 10.

Abstract

Metabolic alterations play a key role in promoting tumor initiation and progression, leading to extensive tumor heterogeneity and adaptability. Thus, targeting abnormal metabolic processes is a promising novel approach for cancer treatment. Numerous pharmacological studies have indicated that many traditional Chinese medicines possess remarkable antitumor activities. Ginsenosides, the main bioactive ingredients of Panax and other types of ginseng, exert beneficial antitumor effects, in addition to the anti-inflammation, anti-oxidant, and anti-fatigue effects. Recently, considerable attention has been paid to the regulation of cancer cell metabolism by ginsenosides. Here, we summarize the structural characteristics and classification of ginsenosides, their antitumor mechanisms, recent progress and the achievements of ginsenoside research in modulating cancer cell metabolism, including the diverse metabolic processes and their regulatory processes, as well as the opportunities and challenges of strategies targeting metabolic vulnerabilities. This review provides novel perspectives on the potential applications of ginsenosides that exert antitumor effects by reshaping cancer metabolism.

Keywords: Antitumor activity; Cancer; Cell metabolism; Ginsenosides; Mechanism.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents
  • Ginsenosides* / chemistry
  • Ginsenosides* / pharmacology
  • Ginsenosides* / therapeutic use
  • Medicine, Chinese Traditional
  • Neoplasms* / drug therapy
  • Panax* / chemistry

Substances

  • Ginsenosides
  • Anti-Inflammatory Agents